Inside Precision Medicine May 22, 2024
The results of two back-to-back randomized double-blind placebo controlled trials has shown that a 100-year-old vaccine originally developed to prevent tuberculosis helps protect people with type 1 diabetes from COVID-19 and other infectious diseases. The research by investigators at the Massachusetts General Hospital (MGH) found that the Bacillus Calmette-Guérin (BCG) vaccine provided continuous protection against all the viral variants for almost the entire COVID-19 pandemic.
The results of the 18-month trial are published today in iScience. The Phase III trial was conducted later in the pandemic when the Omicron variant was circulating in the population. An earlier Phase II trial was conducted earlier in the pandemic, and those results were published in the journal Cell Reports Medicine.
“Individuals with type...